NCT03025711View on ClinicalTrials.gov

Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

October 1, 2018

Study Completion Date

January 31, 2020

Conditions
Breast Neoplasms
Trial Locations (1)

28222

Puerta de Hierro University Hospital, Madrid

All Listed Sponsors
lead

BELEN RUIZ-ANTORAN

OTHER

NCT03025711 - Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine | Biotech Hunter | Biotech Hunter